Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation

内皮细胞和巨噬细胞 ApoER2 在动脉粥样硬化调节中的作用

基本信息

  • 批准号:
    9211369
  • 负责人:
  • 金额:
    $ 69.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-02-01 至 2018-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Genome-wide association analyses have linked variants of the LRP8 gene, including the R952Q LRP8 variant, with premature atherosclerosis and acute myocardial infarction in humans, indicating that its encoded protein apoE receptor-2 (apoER2) has a major impact on cardiovascular health and disease. How apoER2 influences cardiovascular biology is entirely unknown. We recently discovered that apoER2 deletion in LDL receptor-null mice causes marked acceleration of atherogenesis and promotes lesion necrosis without influencing plasma lipoprotein metabolism. The overall goal of this multiple-PI project is to determine how apoER2 in endothelium and macrophages contributes to cardiovascular protection. This will be accomplished by two currently collaborating laboratories with complementary expertise in the study of lipoproteins, lipoprotein receptors and vascular biology. Our recent cell culture work has revealed that through apoER2, apolipoprotein E3 (apoE3) activates endothelial NO synthase (eNOS) and thereby promotes endothelial cell migration, and also blunts endothelial cell-monocyte adhesion. In contrast, apoER2-R952Q has dominant-negative effect on eNOS activation by wild-type receptor. It has further been found that Lrp8-/- mice have impaired reendothelialization. In Aim 1, an apoER2 cytoplasmic domain mutant incapable of adaptor protein interaction and candidate adaptor protein knockdown will be employed to determine the biochemical basis for apoER2 action in endothelium. The underpinnings of apoER2-R952Q dysfunction will also be discerned, and the rescue of cardioprotective behaviors by apoER2-R952Q- expressing endothelial cells will be attempted with NO donor. Using a recently-created floxed Lrp8 mouse, endothelial apoER2 regulation of endothelial cell-leukocyte adhesion will also be studied in vivo by intravital microscopy. Preliminary work has additionally shown that in macrophages apoER2 deficiency causes exaggerated oxLDL-induced neutral lipid accumulation and cell death/apoptosis. Lack of apoER2 in macrophages also results in increases in PPAR� and PPAR�-responsive gene expression. With a focus on PPAR�-mediated processes, in Aim 2 the mechanism(s) by which apoER2 modulates intracellular signaling in macrophages and thereby governs their function and fate will be discerned. In Aim 3, studies will be done using the Lrp8 floxed mouse or bone marrow reconstitution on LDL receptor-null background to determine the contributions of endothelial versus macrophage apoER2 to protection from atherosclerosis progression and plaque necrosis. The planned studies will provide critical new understanding of the basis by which apoER2 and its major ligand apoE influence cardiovascular health. The new information gained promises to improve as well as personalize therapies to combat cardiovascular disease in a large number of individuals with LRP8 variants (~1%) and/or apoE polymorphisms (~15%). The general population may also benefit by the development of novel therapies that harness these processes to optimize cardiovascular protection.
描述(由申请人提供):全基因组关联分析已将LRP 8基因的变体(包括R952 Q LRP 8变体)与人类过早动脉粥样硬化和急性心肌梗死联系起来,表明其编码的蛋白质apoE受体-2(apoER 2)对心血管健康和疾病具有重大影响。apoER 2如何影响心血管生物学是完全未知的。我们最近发现,在LDL受体缺失的小鼠中,apoER 2缺失导致动脉粥样硬化形成显著加速,并促进病变坏死,而不影响血浆脂蛋白代谢。这个多PI项目的总体目标是确定内皮细胞和巨噬细胞中的apoER 2如何有助于心血管保护。这将由目前在脂蛋白、脂蛋白受体和血管生物学研究方面具有互补专长的两个合作实验室完成。我们最近的细胞培养工作表明,载脂蛋白E3(apoE 3)通过apoER 2激活内皮NO合酶(eNOS),从而促进内皮细胞迁移,也钝化内皮细胞-单核细胞粘附。相反,apoER 2-R952 Q对野生型受体激活eNOS具有显性负效应。还发现Lrp 8-/-小鼠具有受损的再内皮化。在目的1中,apoER 2胞质结构域突变体不能衔接蛋白相互作用和候选衔接蛋白敲低将被用来确定内皮细胞中apoER 2作用的生化基础。还将识别apoER 2-R952 Q功能障碍的基础,并且将尝试用NO供体通过表达apoER 2-R952 Q的内皮细胞来挽救心脏保护行为。使用最近创建的floxed Lrp 8小鼠,也将通过活体显微镜在体内研究内皮细胞-白细胞粘附的内皮apoER 2调节。初步研究还表明,在巨噬细胞中,apoER 2缺乏会导致oxLDL诱导的中性脂质蓄积和细胞死亡/凋亡过度。巨噬细胞中apoER 2的缺乏也会导致PPAR γ和PPAR γ反应基因表达的增加。通过关注PPAR β介导的过程,在目标2中,apoER 2调节巨噬细胞细胞内信号传导的机制,从而控制它们的功能和命运。在目标3中,将使用Lrp 8 floxed小鼠或在LDL受体无效背景下的骨髓重建进行研究,以确定内皮细胞与巨噬细胞apoER 2对防止动脉粥样硬化进展和斑块坏死的贡献。计划中的研究将为apoER 2及其主要配体apoE影响心血管健康的基础提供重要的新认识。获得的新信息有望改善和个性化治疗,以对抗大量LRP 8变异体(~1%)和/或apoE多态性(~15%)个体的心血管疾病。一般人群也可能受益于开发利用这些过程来优化心血管保护的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Yiu-Kwan Hui其他文献

David Yiu-Kwan Hui的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Yiu-Kwan Hui', 18)}}的其他基金

Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
多态性 ApoE 处于动脉粥样硬化脂质代谢和炎症十字路口
  • 批准号:
    10533337
  • 财政年份:
    2021
  • 资助金额:
    $ 69.81万
  • 项目类别:
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
多态性 ApoE 处于动脉粥样硬化脂质代谢和炎症十字路口
  • 批准号:
    10363587
  • 财政年份:
    2021
  • 资助金额:
    $ 69.81万
  • 项目类别:
ApoE receptor-2 in vascular disease progression and regression
ApoE 受体 2 在血管疾病进展和消退中的作用
  • 批准号:
    10167112
  • 财政年份:
    2020
  • 资助金额:
    $ 69.81万
  • 项目类别:
ApoE receptor-2 in vascular disease progression and regression
ApoE 受体 2 在血管疾病进展和消退中的作用
  • 批准号:
    10582114
  • 财政年份:
    2019
  • 资助金额:
    $ 69.81万
  • 项目类别:
ApoE receptor-2 in vascular disease progression and regression
ApoE 受体 2 在血管疾病进展和消退中的作用
  • 批准号:
    9761773
  • 财政年份:
    2019
  • 资助金额:
    $ 69.81万
  • 项目类别:
ApoE receptor-2 in vascular disease progression and regression
ApoE 受体 2 在血管疾病进展和消退中的作用
  • 批准号:
    10375435
  • 财政年份:
    2019
  • 资助金额:
    $ 69.81万
  • 项目类别:
ApoE receptor-2 in vascular disease progression and regression
ApoE 受体 2 在血管疾病进展和消退中的作用
  • 批准号:
    9889159
  • 财政年份:
    2019
  • 资助金额:
    $ 69.81万
  • 项目类别:
Intestinal LPC/LPA modulation of gut microbiota and metabolic disease
肠道 LPC/LPA 对肠道微生物群和代谢疾病的调节
  • 批准号:
    9354489
  • 财政年份:
    2016
  • 资助金额:
    $ 69.81万
  • 项目类别:
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation
内皮细胞和巨噬细胞 ApoER2 在动脉粥样硬化调节中的作用
  • 批准号:
    8794465
  • 财政年份:
    2014
  • 资助金额:
    $ 69.81万
  • 项目类别:
Role of Endothelial and Macrophage ApoER2 in Atherosclerosis Modulation
内皮细胞和巨噬细胞 ApoER2 在动脉粥样硬化调节中的作用
  • 批准号:
    8998064
  • 财政年份:
    2014
  • 资助金额:
    $ 69.81万
  • 项目类别:

相似海外基金

Non-invasive coronary thrombus imaging to define the cause of acute myocardial infarction
无创冠状动脉血栓显像可明确急性心肌梗塞的病因
  • 批准号:
    MR/Y009770/1
  • 财政年份:
    2023
  • 资助金额:
    $ 69.81万
  • 项目类别:
    Fellowship
Impact of COVID-19 pandemic on pathophysiology of acute myocardial infarction and emergency cardiovascular care system
COVID-19大流行对急性心肌梗死病理生理学和心血管急诊系统的影响
  • 批准号:
    23K15160
  • 财政年份:
    2023
  • 资助金额:
    $ 69.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Extreme Heat and Acute Myocardial Infarction: Effect Modifications by Sex, Medical History, and Air Pollution
酷热和急性心肌梗塞:性别、病史和空气污染的影响
  • 批准号:
    10709134
  • 财政年份:
    2023
  • 资助金额:
    $ 69.81万
  • 项目类别:
Development of a multi-RNA signature in blood towards a rapid diagnostic test to robustly distinguish patients with acute myocardial infarction
开发血液中的多 RNA 特征以进行快速诊断测试,以强有力地区分急性心肌梗死患者
  • 批准号:
    10603548
  • 财政年份:
    2023
  • 资助金额:
    $ 69.81万
  • 项目类别:
Effectiveness of Strategies to Improve Outcomes after Hospitalization for Acute Myocardial Infarction in Older Adults
改善老年人急性心肌梗死住院后预后的策略的有效性
  • 批准号:
    10576349
  • 财政年份:
    2022
  • 资助金额:
    $ 69.81万
  • 项目类别:
Establishment of the emergency transport decision making program for patients with acute myocardial infarction using artificial intelligence (AI)
利用人工智能(AI)建立急性心肌梗死患者紧急转运决策方案
  • 批准号:
    22K09185
  • 财政年份:
    2022
  • 资助金额:
    $ 69.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of effect of intracoronary supersaturated oxygen therapy on inhibition of no reflow phenomenon in acute myocardial infarction
冠状动脉内过饱和氧治疗抑制急性心肌梗死无复流现象的效果评价
  • 批准号:
    22K08135
  • 财政年份:
    2022
  • 资助金额:
    $ 69.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Developing Federated Learning Strategies for Disease Surveillance Using Cross-Jurisdiction Electronic Medical Records without Data Sharing: With Applications to Acute Myocardial Infarction, Hypertension, and Sepsis Detection
使用跨辖区电子病历(无需数据共享)开发疾病监测联合学习策略:在急性心肌梗塞、高血压和脓毒症检测中的应用
  • 批准号:
    468573
  • 财政年份:
    2022
  • 资助金额:
    $ 69.81万
  • 项目类别:
    Operating Grants
Effectiveness of Strategies to Improve Outcomes after Hospitalization for Acute Myocardial Infarction in Older Adults
改善老年人急性心肌梗死住院后预后的策略的有效性
  • 批准号:
    10339915
  • 财政年份:
    2022
  • 资助金额:
    $ 69.81万
  • 项目类别:
The Personalising Acute Myocardial Infarction Care to improve Outcomes (PAMICO Project)
个性化急性心肌梗死护理以改善结果(PAMICO 项目)
  • 批准号:
    nhmrc : 2005797
  • 财政年份:
    2021
  • 资助金额:
    $ 69.81万
  • 项目类别:
    Partnership Projects
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了